-S2 ELISA plates were coated with PD-L1-Fc at 2μg/ml in 50mM Na 2 CO 3 /NaHCO 3 , pH 9.6 47 .
3
After the plates were washed three times with PBST containing 0.05% blocked with 3% BSA in PBS for 1 hour, serially diluted KN035 were applied to the 5 ELISA plate containing PD-1-hIgG-biotin (10μg/ml) and incubated for 2 hours at 37 °C.
6
Binding was detected with the horseradish peroxidase (HRP)-conjugated goat anti-human 7
IgG, which was developed using tetramethylbenzidine (TMB) substrate and stopped by 8 H 2 SO 4 . The concentration was determined by absorbance at 450 nm.
9
Displacement of PD-1 from PD-1/ PD-L1 complex
10
ELISA plates were coated with PD-L1-Fc at 5μg/ml in 50mM Na 2 CO 3 /NaHCO 3 , pH 9.6 47 .
11
After the plates were washed three times with PBST containing 0.05% Tween-20 and 12 blocked with 1% BSA in PBS for 1 hour, PD1-muFc (1 µg/mL) was added and incubated
13
for 2 hours at room temperature. The results showed that KN035-Fc could specifically bind PD-L1. The positive antibody recognized 8 the corresponding ligands PD-L2 and ICOS. Plates coated with human PD-L1 were incubated with PD1-muFc (1 µg/mL) for 2 hours at RT. 198.3 ng/mL (2.5 nM) and 452.7 ng/ml (3.1 nM), respectively. Durvalumab. IFN-γ levels were determined on day 3, 5, and 7 after the incubation with the 13 antibodies KN035-Fc and Durvalumab (2.51 nM). 
